Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
published in: The Lancet
date of publication: 2008-10-01
language: English
main subject: multiple sclerosis, patient, relapsing-remitting multiple sclerosis, placebo
Cites articles 32
Date
Title
Article - wd:Q46276281